Abstract
Purpose :
Follow up results of aflibercept intravitreal injecton (AII) in choroidal neovascularization secondary a pathologic myopia (MN) after 5 years.
Methods :
15 eyes wiht MN were trated with 2mg AII. BVVA, macular thickness on OCT and FA were evaluated. Follow-up were 5 years
Results :
The mean were: age: 25yrs, refractive error: -10.75D and macular thickness decreased from 352 to 230 micrometers. At 12 months post -treatment mean BCVA increased from 20/100 to 20/50. Only 1 patient lost 35 letters; other 14 increased or stabilized their VA
Conclusions :
These short-term results suggest thet AII are effective and safe and useful in patients with MN
This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.